Moderna Therapeutics, one of the country’s largest biotechnology startups, has hired an in-house veteran as its new general counsel.

In addition to serving as GC, Lori Henderson will be the messenger RNA-based therapeutics company’s corporate secretary and a member of its executive committee. She most recently was senior vice president, GC, corporate secretary and head of business development at Albany Molecular Research Inc. (AMRI). Henderson is Moderna’s second top lawyer, succeeding a GC who left last year, according to a company spokesman, who declined to name that previous legal leader.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]